Navigation Links
Douglas A. McClain, Jr. Resumes CFO Duties at Immunosyn
Date:2/1/2008

LA JOLLA, Calif., Feb. 1 /PRNewswire-FirstCall/ -- Immunosyn Corporation (OTC Bulletin Board: IMYN) has announced that Douglas A. McClain, Jr., will resume the duties of CFO effective February 1, 2008. Mr. McClain also serves as the Company's Chairman of the Board and Corporate Secretary.

At the same time Immunosyn announced the resignation of G. David Criner as the company's Chief Financial and Accounting Officer. Mr. Criner, hired in October 2007, is leaving due to family matters.

"We appreciated David's expertise through this first leg of our development and welcome Douglas A. McClain, Jr. back in his former role as CFO. In the interim we have initiated a candidate search for a permanent CFO," commented Stephen D. Ferrone, CEO and President of Immunosyn Corporation.

About Immunosyn Corporation

La Jolla, CA-headquartered Immunosyn Corporation (OTC Bulletin Board: IMYN) plans to market and distribute life enhancing therapeutics. Currently, the company has exclusive worldwide rights from its largest shareholder, Argyll Biotechnologies, LLC, to market, sell and distribute SF-1019, a compound that was developed from extensive research into Biological Response Modifiers (BRMs). Argyll Biotechnologies, LLC has initiated the process for regulatory approval of SF-1019 in several countries and preparations for clinical trials are underway in both the US and Europe. Research suggests that SF-1019 has the potential to affect a number of clinical conditions including auto-immune disorders such as Multiple Sclerosis (MS), neurological disorders such as Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Reflex Sympathetic Dystrophy Syndrome (RSD or RSDS) and complications from Diabetic Mellitus such as Diabetic Neuropathy (DN) and Diabetic Ulcers (DU).

Except for the historical information contained herein, this press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securit
'/>"/>

SOURCE Immunosyn Corporation
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. Ventas Board Names Ronald G. Geary Audit Committee Chair; Appoints Douglas Crocker II to Fill Vacancy on Audit Committee
2. American Cancer Society to Present Highest Honor to Matthew L. Myers, Douglas R. Lowy, and Mark Schiffman for Outstanding Contributions to Cancer Fight
3. Parker Waichman Alonso LLP, Becnel Law Firm, LLC, Douglas & London P.C., Levin
4. Novadaq Resumes Normal Business Operations by Securing ICG for SPY
5. Immunosyn Corporation Names Stephen Ferrone as CEO
6. Immunosyn Corporation to Begin Trading
7. Equity Research Firm Issued Unauthorized Report and Press Release on Immunosyn Corporation Today
8. Immunosyn Announces the Successful Completion of First Phase Proof of Concept Trial in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)...rengthen Medicare, improve coverage for all Americ.../ -- SUMMARY: Yesterday the United States House ...orm legislation that would strengthen Medicare for...nies that prices millions of Americans out of affo...lth Care for America Act (H.R. 3962) makes prescri...
(Date:11/8/2009)...y of Health holds open house at Victoria campus ,...mber 8, 2009 -- UCW Academy of Health invites anyo...squo;s health care industry to attend their open h..., ,UCW Academy of Health, which offers diplomas i... services, designs its programs to meet the needs ...
(Date:11/8/2009)...-USNewswire/ -- Tonight the House of Representativ...ct, landmark health reform legislation that will e...able, stable and secure health care coverage. The ...rance industry,s worst practices, would extend cov...by $104 billion over ten years. Groups representin...
(Date:11/8/2009)...s Health Network (MHN) urges military veterans to ...inked to exposure to chemicals, atomic agents and ...r is one of those cancers that is two times more p...oked or currently smoke cigarettes. , ...9 -- Men’s Health Network (MHN) kicked-off t...
(Date:11/8/2009)...ispanic health advocates committed to achieving me...TON, Nov. 7 "Tonight th...eard the voice of America,s families by passing th...Senate must deliver, without delay, on the promise...L. Delgado, President and CEO of the National Alli...
Breaking Medicine News(10 mins):Health News:AARP NY Praises House Passage of Health Care Reform Bill 2Health News:AARP NY Praises House Passage of Health Care Reform Bill 3Health News:AARP NY Praises House Passage of Health Care Reform Bill 4Health News:College Invites Public to Explore Career Options in Health Care 2Health News:Democratic National Committee Chairman Tim Kaine Issues Statement Praising the House of Representative's Historic Vote to Pass Health Insurance Reform 2Health News:Democratic National Committee Chairman Tim Kaine Issues Statement Praising the House of Representative's Historic Vote to Pass Health Insurance Reform 3Health News:Veterans' Day Reminder from Men's Health Network: Pay Attention to Bladder Cancer Symptoms and Risk Factors 2Health News:Veterans' Day Reminder from Men's Health Network: Pay Attention to Bladder Cancer Symptoms and Risk Factors 3Health News:National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Health Reform in 2009 2
...ITTSBURGH, Nov. 19 GNC is joining St. Jude Childr...Thanks and Giving campaign.,This is the fourth yea...at,GNC has joined as a partner in the effort. Tha...children of hospital founder Danny Thomas. The cam...
... A protein in mice known as RGS13 suppresses alle...ning allergic reaction known as anaphylaxis, accor...lergy and Infectious Diseases (NIAID), part of the...immune systems mast cells that are central to alle...
...cquisition Marks First Robotic Radiosurgery System...Cancer Treatment Options, SUNNYVALE, Calif., Nov....al leader in the field of radiosurgery,announced t...l be the first CyberKnife System in Russia, giving...
...ALO ALTO, Calif., Nov. 19 Avicena Group,Inc. (OTC... develops,central nervous system therapeutics for ...s. Steven Hersch and Diana Rosas presented results...Drs. Hersch and Rosas, of Massachusetts General Ho...
...esults of the Thomson 100 Top Hospitals(R) Cardiov...nced Today, STAMFORD, Conn., Nov. 19 U.S. hospit...for cardiovascular care also treat,heart patients ...p Hospitals(R): Cardiovascular,Benchmarks for Succ...
...tudy finds farmers are also more likely reach that...News) -- A young, trim farmer with four or more ch... profile for American men hoping to reach 100 year...a large number of offspring all help men live past...
Other Medicine News:Health News:GNC Joins St. Jude Children's Research Hospital(R) to Kick Off Fourth Annual Thanks And Giving(R) Campaign, Asking America to Help Save Children's Lives While Shopping for the Holidays 2Health News:GNC Joins St. Jude Children's Research Hospital(R) to Kick Off Fourth Annual Thanks And Giving(R) Campaign, Asking America to Help Save Children's Lives While Shopping for the Holidays 3Health News:Protein suppresses allergic response in mice 2Health News:Protein suppresses allergic response in mice 3Health News:Leading Russian Cancer Center Acquires CyberKnife(R) System 2Health News:Leading Russian Cancer Center Acquires CyberKnife(R) System 3Health News:Data on Avicena's Drug Candidate HD-02 Presented at the 2007 World Congress on Huntington's Disease 2Health News:Data on Avicena's Drug Candidate HD-02 Presented at the 2007 World Congress on Huntington's Disease 3Health News:Data on Avicena's Drug Candidate HD-02 Presented at the 2007 World Congress on Huntington's Disease 4Health News:Thomson Healthcare Study Finds That Hospitals Delivering High-Quality Heart Care Are Efficient and Cost Effective, Too 2Health News:Thomson Healthcare Study Finds That Hospitals Delivering High-Quality Heart Care Are Efficient and Cost Effective, Too 3Health News:Having Lots of Kids Helps Dads Live to 100 2Health News:Having Lots of Kids Helps Dads Live to 100 3Health News:Having Lots of Kids Helps Dads Live to 100 4
(Date:11/6/2009).... 6 Recession in domesti...ales for Allied Healthcare Products in the first q...09. ,, Sales declines pushed Allied into a loss...s about $745,000, or negative 9 cents per share, c...$208,000, or 3 cents per share. ,, Sales fell ...
(Date:11/6/2009)...J., Nov. 6 Watson Pharma... pharmaceutical company, announced today that Paul...ficer, will provide an overview and update of the ...l Healthcare Conference on Wednesday, November 11,...s presentation will be webcast live and can be acc...
(Date:11/6/2009)...6 Caraco Pharmaceutical ... ketorolac tromethamine ophthalmic solution, 0.5% ...ug Administration (FDA) for Sun Pharma,s Abbreviat...#174; ophthalmic solution on the first day followi...s therapeutically equivalent to Acular® Ophth...
Breaking Medicine Technology:Recession Continues to Depress Sales at Allied Healthcare Products 2Recession Continues to Depress Sales at Allied Healthcare Products 3Recession Continues to Depress Sales at Allied Healthcare Products 4Recession Continues to Depress Sales at Allied Healthcare Products 5Recession Continues to Depress Sales at Allied Healthcare Products 6Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Ophthalmic Solution 2 244 million NCI grant funds comparative effectiveness research at Southwest Oncology Group 59516 1 244 million NCI grant funds comparative effectiveness research at Southwest Oncology Group 59516 2 244 million NCI grant funds comparative effectiveness research at Southwest Oncology Group 59516 3Brown and beige dominate the plate 3A Daily dose of color needed to fill Americas phytonutrient gap 10372 1Brown and beige dominate the plate 3A Daily dose of color needed to fill Americas phytonutrient gap 10372 2Brown and beige dominate the plate 3A Daily dose of color needed to fill Americas phytonutrient gap 10372 3Brown and beige dominate the plate 3A Daily dose of color needed to fill Americas phytonutrient gap 10372 4Bug barcode readers hold out promise of universal vaccines 10368 1Bug barcode readers hold out promise of universal vaccines 10368 2
...RTC 40983 (EPOC),Intergroup Study Results, CHICAGO...of the,randomized phase III EORTC 40983 Intergroup...ime that peri-operative (pre and post,surgery) FOL...nation with a standard chemotherapy regimen for co...iven to patients with,resectable liver metastases ...
...-, CHICAGO, June 04, 2007 /PRNewswire-FirstCall/ -...culizumab), a new treatment for,paroxysmal nocturn...aceuticals, Inc. , is effective in patients diagno... (AA) or myelodysplastic,syndromes (MDS). Soliris ...hemolysis), decreased or eliminated blood transfus...
Other Medicine Technology:The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 2The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 3The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 4The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 5The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 6The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 7The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 8The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 9Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 2Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 3Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 4Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 5Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 6Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 7
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
Medicine Products: